ViiV Healthcare UK Ltd

Stockley Park West, Uxbridge, Middlesex,, UB11 1BT, UK
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328

Patient Information Leaflet last updated on the eMC: 25/11/2010
PIL Epivir Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 25/11/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 23/09/2010 and displayed until 25/11/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 15/06/2010 and displayed until 23/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 05/01/2010 and displayed until 15/06/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/12/2009 and displayed until 05/01/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 11/09/2008 and displayed until 09/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
  • Change to date of revision
  • Change to manufacturer contact details
Updated on 22/03/2007 and displayed until 11/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 22/09/2006 and displayed until 22/03/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 22/09/2006 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 18/04/2005 and displayed until 22/09/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/07/2004 and displayed until 18/04/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 26/03/2004 and displayed until 01/07/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 23/12/2002 and displayed until 26/03/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 22/03/2001 and displayed until 23/12/2002
Reasons for adding or updating:
  • No reasons supplied
Updated on 10/01/2001 and displayed until 22/03/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   lamivudine